37 related articles for article (PubMed ID: 9866001)
1. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.
Cirrincione LR; Penchala SD; Scarsi KK; Podany AT; Winchester LC; Back DJ; Khoo SH; Fletcher CV; Siccardi M; Else LJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():106-112. PubMed ID: 29579732
[TBL] [Abstract][Full Text] [Related]
2. Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China.
Che Y; Taylor D; Luo D; Maldonado LY; Wang M; Wevill S; Vahdat H; Han X; Halpern V; Dorflinger L; Steiner MJ
Contracept X; 2019; 1():100008. PubMed ID: 32494773
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic.
Steiner MJ; Brache V; Taylor D; Callahan R; Halpern V; Jorge A; Wevill S; Sergison J; Venkatasubramanian L; Dorflinger L
Contracept X; 2019; 1():100006. PubMed ID: 32494772
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index.
Natavio M; Stanczyk FZ; Molins EAG; Nelson A; Jusko WJ
Contraception; 2019 May; 99(5):306-311. PubMed ID: 30703352
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.
Blue SW; Winchell AJ; Kaucher AV; Lieberman RA; Gilles CT; Pyra MN; Heffron R; Hou X; Coombs RW; Nanda K; Davis NL; Kourtis AP; Herbeck JT; Baeten JM; Lingappa JR; Erikson DW
Contraception; 2018 Apr; 97(4):363-369. PubMed ID: 29407362
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of gestagens: some problems.
Fotherby K
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
[TBL] [Abstract][Full Text] [Related]
8. Education and counseling for Norplant users.
Hinkle LT
J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
Alvarez F; Brache V; Tejada AS; Cochon L; Faundes A
Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
[TBL] [Abstract][Full Text] [Related]
10. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
11. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
Affandi B; Cekan SZ; Boonkasemsanti W; Samil RS; Diczfalusy E
Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
[TBL] [Abstract][Full Text] [Related]
12. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
14. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
Brache V; Alvarez F; Faundes A; Cochon L; Thevenin F
Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
